Over the forecast period (2019 - 2027), the global intravenous solution market size is projected to grow at a CAGR of 6.1%.

Intravenous solutions (IV) are given to patients to provide sugar, salt, and water directly into their venous circulation. Fluid resuscitation, routine maintenance, replacement, and redistribution are all done with IV solutions and electrolytes. Intravenous medications, nutrition, and blended solutions are now a standard feature of modern therapy. Key companies' adoption of inorganic expansion methods such as collaborations and acquisitions to extend their portfolio of intravenous solutions is projected to drive growth in the global Intravenous Solutions Market. For example, in April 2015, Baxter International Inc. and Laboratoire Aguettant SAS, both based in France, signed a licencing and distribution deal for trace elements, which are critical micronutrients used in parenteral nutrition (PN) therapy.

Increased Intravenous Solution Injection Launches and Regulatory Approvals are projected to drive growth in the Global Intravenous Solution Market.

Intravenous Solutions Market. approvals for intravenous solution injections are likely to fuel the global intravenous solution market growth over the forecast period. For example, in 2015, B. Braun Medical Inc, a subsidiary of B. Braun that specialises in infusion therapy and pain management, stated that their 70 percent Dextrose for Injection in a 2L flexible container had received FDA approval in the United States. 70 percent Dextrose for Injection is an intravenous solution used to restore calories and fluids.

The introduction of Intravenous Solutions Market. solution injections for the treatment of various ailments such as dehydration and gastrointestinal diseases is projected to fuel intravenous solution market growth during the forecast period. For example, Fresenius Kabi USA, LLC, which provides medications and solutions for infusion, transfusion, and clinical nutrition, debuted Vecuronium Bromide for Injection in the United States in 2017. The medication is used to keep neuromuscular blockade and paralysis going.

The market for Intravenous Solutions - Competitive Landscape

Baxter International Inc, ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited are key competitors in the global intravenous solution market.